Virtu Financial’s Metacrine, Inc. Common Stock MTCR Stock Holding History

Virtu Financial’s Portfolio MTCR Stock Details MTCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-28,468	Closed	-$14K	–	2473
2022 Q2	$14K	Buy	+28,468	New	+$13.8K	﹤0.01%	1393
2022 Q1	–	Sell	-122,366	Closed	-$82K	–	2339
2021 Q4	$82K	Buy	+122,366	New	+$218K	0.01%	1212
2021 Q3	–	Sell	-19,671	Closed	-$75K	–	2184
2021 Q2	$75K	Buy	+19,671	New	+$81.3K	0.01%	1264

Other funds holding MTCR

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Virtu Financial's MTCR Position: Q3 2022 in Review

Virtu Financial sold out of Metacrine, Inc. Common Stock (MTCR) in Q3 2022, closing a stake of 28,468 shares — an estimated $14K sold.

Virtu Financial first reported a position in MTCR in Q2 2021 and held it in 3 quarters. The position peaked at $82K in Q4 2021. 27 funds tracked by Wall St. Rank hold MTCR as of Q3 2022.

Virtu Financial reported no remaining Metacrine, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Virtu Financial sold 28,468 Metacrine, Inc. Common Stock shares in Q3 2022, an estimated $14K.
Virtu Financial first reported a position in Metacrine, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
Virtu Financial's Metacrine, Inc. Common Stock position peaked at $82K in Q4 2021.
27 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q3 2022.

Based on Virtu Financial's 13F filing for Q3 2022, filed 7 Nov 2022.